Saudi Aramco Q3 (SAR) adj. net 117.0bln (exp. 107.9bln)
Newsquawk Staff ·
Saudi Aramco Q3 (SAR) adj. net 117.0bln (exp. 107.9bln)
What it means
Aramco results are read less as a single-name story and more as a marker for the integrated energy complex, since its earnings are a direct function of realised crude prices, production policy and downstream margins, and it sits at the top of the regional index by weight. A beat of this kind against consensus has historically drawn a firmer open in the local market and a sympathetic bid in regional and European majors, with the read-across strongest where the driver is price realisations rather than one-off items, so the split between upstream earnings and refining or chemicals margins in the full release matters more than the headline number. Aramco's payout structure, a base dividend plus a variable tranche tied to free cash flow, means the distribution guidance is typically the line that carries the signal for Saudi fiscal flows and for income holders, and management commentary on OPEC+ quota compliance and capacity plans tends to set the tone for the supply narrative into the next ministerial meeting. The follow-ons are the call and any update on the special dividend trajectory, which in past reporting seasons has moved the stock more than the earnings print itself.
- Automakers including GM (GM), Stellantis (STLA) and Volkswagen (VOW3 GY) urge US lawmakers to swiftly pass a permanent ban on Chinese vehicles when they return for the post-election session
- Japan asks Anthropic and OpenAI for more access to advanced AI models, Nikkei reports
- Didi Global (DIDI) has submitted a Hong Kong ride‑hailing licence application, according to Hong Kong Economic Journal
- Vale (VALE) Q3 (USD) net 1.26bln (prev. 2.4bln Y/Y), pro forma EBITDA 3.51bln (exp. 3.32bln), rev. 10.6bln (exp. 10.1bln), iron ore output 88.35mln tons (exp. 91.64mln tons)
- Novo Nordisk (NOVOB DC/NVO) to present new CagriSema and Wegovy data at ObesityWeek 2026, including data on real-world treatment experience with the Wegovy pill
Related headlines
- China's gaming regulator approves 183 domestic games and 12 imported games in October (prev. 206 total in September)4 days ago
- BYD Electronic (0285 HK) 9-month 2026 (RMB): net profit -69.3% Y/Y to CNY 963mln, revenue +3.38% Y/Y 127.46bln 4 days ago
- OpenAI’s Astra model becomes top distillation target for China’s AI labs, while Moonshot AI and DeepSeek utilise OpenAI’s Astra outputs for new models released this month, according to The Information5 days ago
- Silicon Motion (SIMO) Q3 (USD) EPS 4.35 (exp. 3.30), rev. 560mln (exp. 533mln)5 days ago
- Deutsche Telekom (DTE GY) is backing off on a merger with T-Mobile US (TMUS), according to reports5 days ago
- Genmab (GMAB/GMAB DC) announced positive topline results from the global Phase 3 LiGeR-HN1 trial evaluating petosemtamab5 days ago
- Eli Lilly’s (LLY) retatrutide delivered greater A1C reduction and more than double the weight loss of Novo Nordisk’s (NOVOB DC) Ozempic at its highest approved dose in head-to-head trial5 days ago
- TPG pursues USD 5bln acquisition of UK data centre group Ark, according to FT6 days ago
- Syngenta targets at least a USD 66bln valuation in Hong Kong IPO6 days ago
- HP (HPQ), Asus (2357 TT) and Acer (2353 TT) are shifting some PC production from Thailand and Vietnam back to China to combat soaring component costs driven by AI-related memory and storage shortages, reports Nikkei citing sources6 days ago
- Universal Music Group (UMG NA) discusses going private with buyout firms, according to Bloomberg7 days ago
- Japan's Sakana AI to build homegrown model to cut US and China reliance, reports Nikkei7 days ago
- Japan's Sakana AI to build homegrown model to cut US and China reliance, Nikkei reports7 days ago
- Foxconn (2317 TT) has brought online an AI factory powered by an NVIDIA (NVDA) DGX supercomputing cluster7 days ago
- US FDA has approved Novo's (NOVOB DC) once-weekly insulin treatment for paediatric patients with type 2 diabetes mellitusOct 23